| pubmed-article:2364157 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2364157 | lifeskim:mentions | umls-concept:C0023418 | lld:lifeskim |
| pubmed-article:2364157 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:2364157 | lifeskim:mentions | umls-concept:C0013089 | lld:lifeskim |
| pubmed-article:2364157 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:2364157 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
| pubmed-article:2364157 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:2364157 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:2364157 | lifeskim:mentions | umls-concept:C0729161 | lld:lifeskim |
| pubmed-article:2364157 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2364157 | pubmed:dateCreated | 1990-8-15 | lld:pubmed |
| pubmed-article:2364157 | pubmed:abstractText | Using hybrid mice BDF1 doxorubicin (Dx) accumulation has been determined in leukemia P388 cells (P388/0), P388 cells with induced resistance to Dx (P388/Dx) and P388 cells with induced resistance to the finoptin (Fp) + Dx combination (P388/Fp + Dx). It has been shown that Fp doesn't affect Dx accumulation in or elimination from leukemia cells P388/0 or P388/Fp + Dx. The resistance of P388/Fp + Dx cells to the Fp + Dx combination develops during 6 passages. It can be concluded that Fp application doesn't abolish the problem of tumor cells' resistance to cytostatics. | lld:pubmed |
| pubmed-article:2364157 | pubmed:language | rus | lld:pubmed |
| pubmed-article:2364157 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2364157 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2364157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2364157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2364157 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2364157 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:2364157 | pubmed:issn | 0365-9615 | lld:pubmed |
| pubmed-article:2364157 | pubmed:author | pubmed-author:MorozL VLV | lld:pubmed |
| pubmed-article:2364157 | pubmed:author | pubmed-author:DonenkoF VFV | lld:pubmed |
| pubmed-article:2364157 | pubmed:author | pubmed-author:KabievaA OAO | lld:pubmed |
| pubmed-article:2364157 | pubmed:author | pubmed-author:SitdikovaS... | lld:pubmed |
| pubmed-article:2364157 | pubmed:author | pubmed-author:BorovkovaN... | lld:pubmed |
| pubmed-article:2364157 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2364157 | pubmed:volume | 109 | lld:pubmed |
| pubmed-article:2364157 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2364157 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2364157 | pubmed:pagination | 290-2 | lld:pubmed |
| pubmed-article:2364157 | pubmed:dateRevised | 2008-10-8 | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:meshHeading | pubmed-meshheading:2364157-... | lld:pubmed |
| pubmed-article:2364157 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2364157 | pubmed:articleTitle | [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin]. | lld:pubmed |
| pubmed-article:2364157 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2364157 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2364157 | pubmed:publicationType | English Abstract | lld:pubmed |
